Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/26/2012WO2012098090A1 Cb2 agonists for the treatment and prevention of endometriosis
07/26/2012WO2012098070A1 Quinoline dyrk1 inhibitors
07/26/2012WO2012098068A1 Pyrazolo pyrimidines as dyrk1a and dyrk1b inhibitors
07/26/2012WO2012098066A1 1,6- and 1,8-naphthyridines useful as dyrk1 inhibitors
07/26/2012WO2012098065A1 Pyrido pyrimidines for use as dyrk1 inhibitors
07/26/2012WO2012098064A1 1,4 oxazines as bace1 and/or bace2 inhibitors
07/26/2012WO2012098033A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
07/26/2012WO2012098000A1 Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
07/26/2012WO2012097978A2 Pharmaceutical compositions of immunosuppressants
07/26/2012WO2012097876A1 Corona-like (guanidyl)-oligosaccharidic derivatives as cell-penetrating enhancers for intracellular delivery of colloidal therapeutic systems
07/26/2012WO2012097869A1 Derivatives of nicotinic acid n-oxide, their preparation and their use as inhibitors of enzyme 3-hydroxyanthranilate-3,4-dioxygenase
07/26/2012WO2012097867A1 Cladribine particles and pharmaceutical compositions comprising them
07/26/2012WO2012097750A1 Pyrazolopyrimidinone compound and imidazo-triazone compound for treating erectile dysfunction
07/26/2012WO2012097744A1 Mineralocorticoid receptor antagonists
07/26/2012WO2012097697A1 Organic amine salts of azilsartan, preparation method and use thereof
07/26/2012WO2012097684A1 Bicyclic carboxamide inhibitors of kinases
07/26/2012WO2012097683A1 Bicyclic inhibitors of alk
07/26/2012WO2012097682A1 Bicyclic inhibitors of alk
07/26/2012WO2012097640A1 Use of 3'4-dihydroxy-3, 5'-dimethoxybibenzil in the manufacture of medicaments for treating cataract
07/26/2012WO2012097550A1 Cyclohydrocarbyl formamide derivatives, preparation methods and uses thereof
07/26/2012WO2012097518A1 Medicament for treating acne
07/26/2012WO2012097479A1 Bicyclic inhibitors of anaphastic lymphoma kinase
07/26/2012WO2012097478A1 Bicyclic carboxamide inhibitors of kinases
07/26/2012WO2012097454A1 Compounds for use in the treatment of bacterial infection
07/26/2012WO2012097428A1 Compounds and pharmaceutical compositions for uses in diabetes
07/26/2012WO2012097427A1 Compounds and compositions for the treatment of cancer
07/26/2012WO2012097420A1 Pharmaceutical composition for treating oxidative stress-induced pathology and use thereof
07/26/2012WO2012078674A8 Substituted indole/indazole-pyrimidinyl compounds
07/26/2012WO2012077968A3 Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
07/26/2012WO2012075492A3 Carbocycle-substituted purine and 7-deazapurine compounds
07/26/2012WO2012075210A3 Method for treating refractory cancer
07/26/2012WO2012075174A3 Compounds and methods for skin repair
07/26/2012WO2012074904A3 Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents
07/26/2012WO2012074830A3 Modified release tranexamic acid formulation
07/26/2012WO2012074244A3 Injectable liquid composition or injectable dried powder containing revaprazan or its salt
07/26/2012WO2012074243A3 Injectable liquid composition containing revaprazan or its salt
07/26/2012WO2012071573A3 Materials and methods for the prevention and treatment of cancer
07/26/2012WO2012068380A3 Methods and compositions for modulating pd1
07/26/2012WO2012068355A3 Treating aortic aneurysm by modulating toll-like receptors
07/26/2012WO2012066565A3 Asenapine maleate amorphous and crystalline form and process for preparation thereof
07/26/2012WO2012066488A3 Bridged spiro[2.4]heptane ester derivatives
07/26/2012WO2012065182A3 Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders
07/26/2012WO2012065028A3 Substituted tetracyclines
07/26/2012WO2012064973A3 Heterocyclic compounds and uses thereof
07/26/2012WO2012064923A3 Compounds and methods for treating multiple sclerosis
07/26/2012WO2012064230A3 Digestive tract detoxicant for vertebrates
07/26/2012WO2012061012A3 4-amino-2h-pyran-2-one analogs as anticancer agents
07/26/2012WO2012060791A3 Production method for pharmaceutical compositions comprising cefdinir
07/26/2012WO2012060786A3 Cefpodoxime proxetil formulations comprising viscosity agent
07/26/2012WO2012058673A3 Enhanced cancer treatment and monitoring using recombinant vectors
07/26/2012WO2012058219A3 Deuterium enriched rasagiline
07/26/2012WO2012056327A3 A method for increasing the replication of oncolytic hsvs in highly resistant tumor cells using mtor pathway and pi3k inhibitors
07/26/2012WO2012054535A3 Compounds, compositions and methods useful for cholesterol mobilisation
07/26/2012WO2012053787A3 Aryloxy phenoxy acrylic compound having hif-1 inhibition activity, method for preparing same, and pharmaceutical composition containing same as an active ingredient
07/26/2012WO2012052169A3 Particulate pharmaceutical composition containing an opioid and an opioid antagonist
07/26/2012WO2012051410A3 Heteroaryls and uses thereof
07/26/2012WO2012051407A3 Molecular containers and methods of making and using same
07/26/2012WO2012050393A3 Novel compound of a reverse-turn mimetic and a production method and use therefor
07/26/2012WO2012048202A3 Method of preparation of antiviral compounds and useful intermediates thereof
07/26/2012WO2012048129A3 Inhibitors of polo-like kinase
07/26/2012WO2012039768A3 Itraconazole formulations
07/26/2012WO2012037485A8 Methods of inhibiting alphavirus replication and treating alphavirus infection
07/26/2012WO2012033353A3 Sesterterpene compounds and use thereof
07/26/2012WO2012025730A3 Soluble film
07/26/2012WO2012021891A4 Compositions, kits and methods for treatment of complement-related disorders
07/26/2012WO2012010669A3 Medicinal drug for oral administration comprising a mixture of silodosin and a basic copolymer
07/26/2012WO2011157428A3 In-situ lecithin microemulsion gel formulation
07/26/2012WO2011107921A3 Modified release composition of milnacipran
07/26/2012WO2011107283A3 Formulations of taurolidine and method for the production thereof
07/26/2012WO2011097946A8 Oxazolidinone compounds containing ring-fused bicyclic ring, preparation method and use thereof
07/26/2012WO2011083150A3 Obesity small molecules
07/26/2012US20120191068 Methods for Sustained Treatment of Bladder Pain and Irritative Voiding
07/26/2012US20120191039 Carrier linked pramipexole prodrugs
07/26/2012US20120190861 Levodopa Prodrugs, and Compositions and Uses Thereof
07/26/2012US20120190832 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
07/26/2012US20120190753 Compositions Containing Aromatic Aldehydes and Their Use in Treatments
07/26/2012US20120190752 Exo-s-mecamylamine method, use, and compound for treatment
07/26/2012US20120190751 Compounds for treatments of inflammation
07/26/2012US20120190750 Stable ready to use injectable paracetamol formulation
07/26/2012US20120190748 Greater utility with thyroid hormone
07/26/2012US20120190747 Method of treatment using fatty acid synthesis inhibitors
07/26/2012US20120190745 Oral composition for reducing wrinkle formation
07/26/2012US20120190743 Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity
07/26/2012US20120190742 Method for treating eczema
07/26/2012US20120190741 Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof
07/26/2012US20120190740 Use of dronedarone for the preparation of a drug for use in the management of the risk of liver injury
07/26/2012US20120190739 Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection
07/26/2012US20120190738 Inhibitors of phosphatidylinositol-3-kinase (pi3) and inducers of nitric oxide (no)
07/26/2012US20120190737 Fatty Acid Formulations and Methods of Use Thereof
07/26/2012US20120190736 Method of managing broncho-constrictive condition
07/26/2012US20120190735 Cancer Cell Apoptosis
07/26/2012US20120190734 Compounds and compositions for treating infection
07/26/2012US20120190733 Compounds and methods for enhancing hair growth
07/26/2012US20120190732 Multifunctional Aptamer-Nucleic Acid Nanostructures for Tumor-Targeted Killing
07/26/2012US20120190731 Methods and compositions to reduce oxidative stress
07/26/2012US20120190730 Targeting cells with altered microrna expression
07/26/2012US20120190729 Mirna inhibition of six1 expression
07/26/2012US20120190728 Compositions and methods for modulation of smn2 splicing in a subject
07/26/2012US20120190727 Method and means for treatment of osteoarthritis
07/26/2012US20120190726 Functionalized polysaccharides for active agent delivery
1 ... 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 ... 7860